These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32540603)

  • 1. Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19.
    Maldonado V; Loza-Mejía MA; Chávez-Alderete J
    Med Hypotheses; 2020 Nov; 144():109988. PubMed ID: 32540603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19.
    Mostafa-Hedeab G; Al-Kuraishy HM; Al-Gareeb AI; Jeandet P; Saad HM; Batiha GE
    Inflammopharmacology; 2022 Jun; 30(3):799-809. PubMed ID: 35486310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
    Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing adenosine A2A receptors as a strategy for suppressing the lung inflammation and thrombotic complications of COVID-19: Potential of pentoxifylline and dipyridamole.
    DiNicolantonio JJ; Barroso-Aranda J
    Med Hypotheses; 2020 Oct; 143():110051. PubMed ID: 32650197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptors: Impact for COVID-19 severity.
    Aksoy H; Karadag AS; Wollina U
    Dermatol Ther; 2020 Nov; 33(6):e13989. PubMed ID: 32645228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
    Tseng YH; Yang RC; Lu TS
    Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment.
    Lumbers ER; Head R; Smith GR; Delforce SJ; Jarrott B; H Martin J; Pringle KG
    Pharmacol Res Perspect; 2022 Feb; 10(1):e00917. PubMed ID: 35106954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
    Hu Y; Liu L; Lu X
    Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology.
    Vieira C; Nery L; Martins L; Jabour L; Dias R; Simões E Silva AC
    Curr Drug Targets; 2021; 22(3):254-281. PubMed ID: 33081670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
    Danser AHJ; Epstein M; Batlle D
    Hypertension; 2020 Jun; 75(6):1382-1385. PubMed ID: 32208987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
    Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
    Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs acting on the renin-angiotensin system and SARS-CoV-2.
    Vitiello A; Pelliccia C; Ferrara F
    Drug Discov Today; 2021 Apr; 26(4):870-874. PubMed ID: 33486116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19.
    Lu L; Liu X; Jin R; Guan R; Lin R; Qu Z
    Biomed Res Int; 2020; 2020():7520746. PubMed ID: 33204713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentoxifylline decreases serum LDH levels and increases lymphocyte count in COVID-19 patients: Results from an external pilot study.
    Maldonado V; Hernandez-Ramírez C; Oliva-Pérez EA; Sánchez-Martínez CO; Pimentel-González JF; Molina-Sánchez JR; Jiménez-Villalba YZ; Chávez-Alderete J; Loza-Mejía MA
    Int Immunopharmacol; 2021 Jan; 90():107209. PubMed ID: 33278747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
    Datta PK; Liu F; Fischer T; Rappaport J; Qin X
    Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure.
    Kang YM; Zhang ZH; Xue B; Weiss RM; Felder RB
    Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H227-36. PubMed ID: 18487441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
    Malek Mahdavi A
    Rev Med Virol; 2020 Sep; 30(5):e2119. PubMed ID: 32584474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What would Sérgio Ferreira say to your physician in this war against COVID-19: How about kallikrein/kinin system?
    Nicolau LAD; Magalhães PJC; Vale ML
    Med Hypotheses; 2020 Oct; 143():109886. PubMed ID: 32504925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.
    Offringa A; Montijn R; Singh S; Paul M; Pinto YM; Pinto-Sietsma SJ
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):317-325. PubMed ID: 32464637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.